Donate

News

 

Women in Lymphoma join Lymphoma Australia

Lymphoma Australia officially welcomes Women in Lymphoma

Joint statement: 30 June 2022

From 1 July 2022, the international professional alliance Women in Lymphoma will be supported through Lymphoma Australia, transitioning from the Snowdome Foundation.

Women in Lymphoma is an alliance of 180+ lymphoma doctors, researchers and educators from around the world including USA, Canada, South America, United Kingdom, France, Spain, the Netherlands, Germany, Australia, New Zealand, Singapore and beyond. The group’s focus is to advocate for leadership for women in lymphoma.

“Snowdome Foundation is very proud to have supported the global Women in Lymphoma (WiL) initiative since establishment in October 2020.
Snowdome – having delivered on its promise to lend administrative and governance support to WiL, enabling them to greatly expand over the past 18 months – is very pleased to announce WiL’s move to their new home at Lymphoma Australia where they are best placed for their next stage of growth.”

Lymphoma Australia look forward to supporting them in their mission to support and advocate for greater leadership of women in lymphoma globally. 
Women in Lymphoma also encourages the involvement of leading men in lymphoma, as champions of change, to work with WiL on initiatives to identify and reduce barriers which may prevent women choosing or being for a leadership path in lymphoma.

Please see attached the joint announcement from WiL, Lymphoma Australia and Snowdome Foundation regarding the transition of WiL to governance with Lymphoma Australia.

 

Contact:
Anna Steiner, Executive Administrator – Women in Lymphoma @ Lymphoma Australia
www.womeninlymphoma.org  |  wil@lymphoma.org.au

 

Share This
Cart
Checkout - $0.00
  • 0
  • 1

Contact Lymphoma Australia Today!

Patient Support Hotline

General Enquiries

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.